ValiRx Statistics

Total Valuation

ValiRx has a market cap or net worth of GBP 1.68 million. The enterprise value is -261,241.

Market Cap	1.68M
Enterprise Value	-261,241

Important Dates

The last earnings date was Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ValiRx has 374.35 million shares outstanding. The number of shares has increased by 30.08% in one year.

Current Share Class	374.35M
Shares Outstanding	374.35M
Shares Change (YoY)	+30.08%
Shares Change (QoQ)	+28.20%
Owned by Insiders (%)	19.93%
Owned by Institutions (%)	70.94%
Float	295.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.84
PB Ratio	0.43
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.16

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.00.

Current Ratio	5.50
Quick Ratio	5.30
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-1,674.49

Financial Efficiency

Return on equity (ROE) is -58.74% and return on invested capital (ROIC) is -39.06%.

Return on Equity (ROE)	-58.74%
Return on Assets (ROA)	-36.21%
Return on Invested Capital (ROIC)	-39.06%
Return on Capital Employed (ROCE)	-54.68%
Revenue Per Employee	3,111
Profits Per Employee	-119,731
Employee Count	16
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-127,696
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.93% in the last 52 weeks. The beta is -0.47, so ValiRx's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	-83.93%
50-Day Moving Average	0.51
200-Day Moving Average	1.00
Relative Strength Index (RSI)	29.35
Average Volume (20 Days)	1,636,866

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ValiRx had revenue of GBP 49,775 and -1.92 million in losses. Loss per share was -0.01.

Revenue	49,775
Gross Profit	49,775
Operating Income	-2.14M
Pretax Income	-2.13M
Net Income	-1.92M
EBITDA	-1.87M
EBIT	-2.14M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 1.56 million in cash and 11,862 in debt, giving a net cash position of 1.54 million or 0.00 per share.

Cash & Cash Equivalents	1.56M
Total Debt	11,862
Net Cash	1.54M
Net Cash Per Share	0.00
Equity (Book Value)	3.92M
Book Value Per Share	0.03
Working Capital	1.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.58 million and capital expenditures -38,156, giving a free cash flow of -1.62 million.

Operating Cash Flow	-1.58M
Capital Expenditures	-38,156
Free Cash Flow	-1.62M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,302.70%
Pretax Margin	-4,280.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ValiRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.08%
Shareholder Yield	n/a
Earnings Yield	-113.72%
FCF Yield	-96.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 6, 2020. It was a reverse split with a ratio of 0.008.

Last Split Date	Apr 6, 2020
Split Type	Reverse
Split Ratio	0.008

Scores

ValiRx has an Altman Z-Score of -7.31 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.31
Piotroski F-Score	5